AIF1 and Alzheimer disease: In contrast, long-term Avn-C treatment initiated from the early AD stage in 5xFAD mice showed significantly suppressed Iba1 expression by ~90% relative to 5xFAD vehicles (p < 0.001), with no significant difference between WT and Avn-C-treated 5xFAD mice (p > 0.05).